Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with early-stage prostate cancer, confirmed through a tissue or cell sample test.
- Your cancer is classified as either "low-risk" or "favorable intermediate-risk" based on specific test results, including your PSA level, Gleason score, and biopsy results (confirm with trial site if unsure of your risk category).
- You may have already started hormone therapy (to lower testosterone), as long as it began no more than 6 months before the planned treatment, and the total course of hormone therapy is between 4 and 36 months.
- You are at least 18 years old.
- You are able to carry out daily activities with no more than some limitations due to your health (confirm with trial site what level of physical fitness is required).
- You are able to understand the study information and are willing to sign a consent form agreeing to take part.
Who may not be able to join:
- You have previously had radiation therapy to the prostate or the lower belly/pelvic area.
- You have had another type of cancer within the last 5 years, unless it was a certain type of skin cancer (basal cell or squamous cell) that was fully removed with minor surgery.
- You are currently taking part in another clinical trial involving an experimental treatment.
- You have a serious uncontrolled illness, such as an active infection, heart failure, chest pain, or an irregular heartbeat.
- You are unable to receive any form of anesthesia (general, spinal, or local).
- You have had a previous prostate procedure (called a TURP) that left a large enough defect that your doctor believes it would interfere with the planned treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hiram A Gay, M.D., Washington University School of Medicine
Phone: 314-362-8516
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Biochemical control experienced by patients with prostate cancer treated with an HDR implant
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.